List of articles with "Johnson & Johnson"

CAPLYTA® New Submission

CAPLYTA® New Submission

United States Johnson & Johnson schizophrenia Titusville CAPLYTA
Tarbey® Approved

Tarbey® Approved

Japan Johnson & Johnson Tokyo Multiple Myeloma Tarbey®
ACUVUE OASYS MAX Launch

ACUVUE OASYS MAX Launch

USA Johnson & Johnson Jacksonville Contact Lenses ACUVUE OASYS
Talc Litigation Update

Talc Litigation Update

United States Johnson & Johnson Legal-Bay Trenton Talc Litigation
TECNIS Odyssey IOL Launch

TECNIS Odyssey IOL Launch

United States Johnson & Johnson Jacksonville TECNIS Odyssey IOL
TALVEY and TECVAYLI Results

TALVEY and TECVAYLI Results

United States Johnson & Johnson New Brunswick TALVEY TECVAYLI
New CAR T-Cell Therapy

New CAR T-Cell Therapy

USA Milan Johnson & Johnson CAR T-Cell JNJ-4496
Bleximenib Phase 1b Results

Bleximenib Phase 1b Results

United States Johnson & Johnson New Brunswick AML Bleximenib
J&J New Myeloma Treatment

J&J New Myeloma Treatment

USA Chicago Johnson & Johnson Multiple Myeloma JNJ-79635322
CARVYKTI® Long-Term Remission

CARVYKTI® Long-Term Remission

United States Chicago Johnson & Johnson Multiple Myeloma CARVYKTI
DARZALEX FASPRO® Success

DARZALEX FASPRO® Success

USA Chicago Johnson & Johnson Multiple Myeloma DARZALEX FASPRO
Hope for Prostate Cancer

Hope for Prostate Cancer

USA Chicago Johnson & Johnson Prostate Cancer AKEEGA
KINCISE™ 2 Launch

KINCISE™ 2 Launch

United States Johnson & Johnson Palm Beach Gardens KINCISE Surgical System
Promising Cancer Treatment

Promising Cancer Treatment

United States Chicago Johnson & Johnson Prostate Cancer pasritamig
Revolutionizing Intracardiac Imaging

Revolutionizing Intracardiac Imaging

United States Johnson & Johnson Irvine SOUNDSTAR CRYSTAL CARTO 3 System
Tremfya® Released

Tremfya® Released

Japan Ulcerative Colitis TREMFYA® Johnson & Johnson Tokyo
FDA Backs DARZALEX FASPRO®

FDA Backs DARZALEX FASPRO®

United States Johnson & Johnson Multiple Myeloma Raritan, NJ DARZALEX FASPRO®
Tremfya® Long-Term Results

Tremfya® Long-Term Results

USA San Diego Ulcerative Colitis Johnson & Johnson TREMFYA
Icotrokinra's Promising Efficacy

Icotrokinra's Promising Efficacy

USA Johnson & Johnson Spring House Psoriasis Icotrokinra
ACTO Welcomes Lori Tierney

ACTO Welcomes Lori Tierney

USA Johnson & Johnson ACTO Lori Tierney Toronto/New York
Personalized Health Plans

Personalized Health Plans

Johnson & Johnson United Kingdom Leeds health data Personalized Treatment
TREMFYA® Outperforms in UC

TREMFYA® Outperforms in UC

United States San Diego Ulcerative Colitis Johnson & Johnson TREMFYA
FDA Approves IMAAVY

FDA Approves IMAAVY

United States Johnson & Johnson Spring House Myasthenia Gravis IMAAVY
Promising TAR-200 Efficacy

Promising TAR-200 Efficacy

USA Johnson & Johnson Las Vegas Bladder Cancer TAR-200
J&J MedTech Trial Results

J&J MedTech Trial Results

United States Johnson & Johnson Irvine Atrial Fibrillation OMNYPULSE™
TECNIS Odyssey Insights

TECNIS Odyssey Insights

USA Los Angeles Johnson & Johnson TECNIS Odyssey IOL
Weekly Health Highlights

Weekly Health Highlights

United States New York Johnson & Johnson infant immunization AI Disease Detection
Cancer Risks and Antipsychotics

Cancer Risks and Antipsychotics

USA Johnson & Johnson Alameda Eli Lilly Risperdal
J&J's New Bladder Cancer Data

J&J's New Bladder Cancer Data

USA Johnson & Johnson Las Vegas Bladder Cancer TAR-200
Talc Cancer Fight

Talc Cancer Fight

United States Dallas Johnson & Johnson Nachawati Law Group Talcum Powder
Weekly Health Roundup

Weekly Health Roundup

United States New York Johnson & Johnson Pediatric Health Novo Nordisk
OTTA VA's First Cases

OTTA VA's First Cases

United States Johnson & Johnson New Brunswick Robotic Surgery OTTAVA
Icotrokinra and Teen Psoriasis

Icotrokinra and Teen Psoriasis

United States Johnson & Johnson Spring House Icotrokinra Plaque Psoriasis
Nipocalimab Efficacy

Nipocalimab Efficacy

United States Johnson & Johnson nipocalimab Myasthenia Gravis Spring House, Pennsylvania
TREMFYA® for PsA

TREMFYA® for PsA

Johnson & Johnson TREMFYA Psoriatic Arthritis
Heart Treatment Innovations

Heart Treatment Innovations

USA Chicago Johnson & Johnson Impella heart recovery
Nipocalimab Insights

Nipocalimab Insights

United States San Diego Johnson & Johnson nipocalimab Myasthenia Gravis
Nipocalimab Advances Treatment

Nipocalimab Advances Treatment

United States Johnson & Johnson Spring House nipocalimab Sjögren's Disease
Icotrokinra's Promising Results

Icotrokinra's Promising Results

United States Ulcerative Colitis Johnson & Johnson Spring House Icotrokinra
Digital Orthopaedics Innovation

Digital Orthopaedics Innovation

United States Johnson & Johnson MedTech San Diego, California AAOS 2025
Icotrokinra in Psoriasis

Icotrokinra in Psoriasis

United States Johnson & Johnson Spring House Icotrokinra Plaque Psoriasis
Nipocalimab Insights

Nipocalimab Insights

United States Johnson & Johnson Spring House nipocalimab Autoantibody Diseases
J&J Fraud Investigation

J&J Fraud Investigation

United States New York Johnson & Johnson Pomerantz LLP NYSE JNJ
Pomerantz Reviews J&J

Pomerantz Reviews J&J

USA New York Johnson & Johnson Pomerantz LLP JNJ
Johnson & Johnson Fraud Inquiry

Johnson & Johnson Fraud Inquiry

United States New York Johnson & Johnson Pomerantz LLP JNJ
TAR-200 Drug Application

TAR-200 Drug Application

United States Johnson & Johnson Raritan Bladder Cancer TAR-200
Trellus Health’s New Partnership

Trellus Health’s New Partnership

United States New York Johnson & Johnson IBD Trellus Health
New Cardiac Catheter CE Mark

New Cardiac Catheter CE Mark

None Johnson & Johnson MedTech Irvine THERMOCOOL
Arkuda & Johnson

Arkuda & Johnson

USA Johnson & Johnson Watertown Neurodegenerative Diseases Arkuda Therapeutics
FDA Fast Track Approval

FDA Fast Track Approval

United States Johnson & Johnson Alzheimer’s Disease Posdinemab Titusville

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.